Study says that there was an increased number of deaths at 15 days in severe COVID-19 patients receiving tocilizumab
Study says that there was an increased number of deaths at 15 days in severe COVID-19 patients receiving tocilizumab
Disclaimer: Stories/articles published under EM Buzz (eastmojo.com/em-buzz) are provided by third parties and EastMojo.com has no direct relation with these articles.
Sign in to activate your ad-free experience.
Enter your membership email and we'll send you a secure login link.
Not a member yet? Become a Member →